DrugPatentWatch Database Preview
ZYRTEC HIVES RELIEF Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Zyrtec Hives Relief, and what generic alternatives are available?
Zyrtec Hives Relief is a drug marketed by J And J Consumer Inc and is included in one NDA.
The generic ingredient in ZYRTEC HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-three suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
US ANDA Litigation and Generic Entry Outlook for Zyrtec Hives Relief
A generic version of ZYRTEC HIVES RELIEF was approved as cetirizine hydrochloride by TEVA PHARMS on January 21st, 2020.
Summary for ZYRTEC HIVES RELIEF
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 95 |
| Clinical Trials: | 28 |
| Patent Applications: | 1,867 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ZYRTEC HIVES RELIEF at DailyMed |
Recent Clinical Trials for ZYRTEC HIVES RELIEF
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division | Phase 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Early Phase 1 |
| Northwestern University | Early Phase 1 |
Synonyms for ZYRTEC HIVES RELIEF
| (+-)-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)acetic acid, dihydrochloride |
| (+) {2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazine-1-yl] -ethoxy}-acetic acid dihydrochloride |
| (+/-)-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]acetic acid, dihydrochloride |
| (+/-){2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]-ethoxy}-acetic acid dihydrochloride |
| (2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid dihydrochloride |
| (R)-2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride |
| (RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy }-acetic acid dihydrochloride |
| (RS)-{2-[4-(alpha-phenyl-p-chlorobenzyl)-piperazin-1-yl]ethoxy}-acetic acid dihydrochloride |
| [2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]aceticaciddihydrochloride |
| 130018-82-5 |
| 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanoic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid dihydrochloride |
| 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid;dihydrochloride |
| 83881-51-0 (Parent) |
| 83881-52-1 |
| 881C510 |
| A840675 |
| AB0008484 |
| AB1009381 |
| AC-1600 |
| AC1L1IJL |
| Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride |
| Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, dihydrochloride, (+-)- |
| AKOS000280979 |
| AKOS016340521 |
| Alercet |
| Alergex |
| Alerid |
| Alerlisin |
| Alertisin |
| Allergy relief |
| Alleroff |
| AN-14770 |
| ANW-69482 |
| API0001938 |
| Apo-Cetirizine |
| AX8022801 |
| BCP09018 |
| BG0436 |
| C21H25ClN2O3.2HCl |
| C21H27Cl3N2O3 |
| CAS-83881-52-1 |
| CC0256 |
| CCG-213404 |
| Cetalerg |
| Ceterifug |
| Ceti TAD |
| Ceti-Puren |
| Cetiderm |
| Cetidura |
| Cetil von ct |
| CetiLich |
| Cetirigamma |
| Cetirizin AZU |
| Cetirizin Basics |
| Cetirizin dihydrochloride, >=98.0% (HPLC) |
| Cetirizine (dihydrochloride) |
| Cetirizine Di |
| Cetirizine diHCl |
| Cetirizine dihydrochloride |
| Cetirizine Dihydrochloride 1.0 mg/ml in Water (as free base) |
| Cetirizine dihydrochloride solution, 1.0 mg/mL in acetonitrile: water (9:1) (as free base), ampule of 1 mL, certified reference material |
| Cetirizine dihydrochloride, >=98% (HPLC) |
| Cetirizine dihydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Cetirizine dihydrochloride, United States Pharmacopeia (USP) Reference Standard |
| Cetirizine for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Cetirizine HCl |
| CETIRIZINE HYDROCHLORIDE |
| Cetirizine hydrochloride (JP17/USAN) |
| Cetirizine hydrochloride [USAN:USP] |
| Cetirizine hydrochloride [USAN] |
| Cetirizine Hydrochloride Allergy |
| Cetirizine Hydrochloride Hives |
| Cetirizine hydrochloride, British Pharmacopoeia (BP) Reference Standard |
| Cetirizine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material |
| cetirizinedihydrochloride |
| Cetirlan |
| Cetriler |
| Cetrine |
| Cetzine |
| Cezin |
| CHEBI:3562 |
| CHEMBL1607273 |
| Children's Cetirizine hydrochloride allergy |
| Children's Cetirizine hydrochloride hives relief |
| Children's Zyrtec |
| Children's Zyrtec Allergy |
| Children's Zyrtec Hives Relief |
| CS-1798 |
| CTK8C2999 |
| D00664 |
| DSSTox_CID_24268 |
| DSSTox_GSID_44268 |
| DSSTox_RID_80138 |
| DTXSID2044268 |
| Formistin |
| FT-0603000 |
| HMS1569F07 |
| HMS1922H04 |
| HY-17042A |
| I06-0389 |
| J10151 |
| KS-000015AD |
| KS-1042 |
| LP00362 |
| LS-11411 |
| MolPort-000-832-941 |
| NCGC00016949-01 |
| NCGC00095180-01 |
| NCGC00095180-02 |
| NCGC00255965-01 |
| NCGC00261047-01 |
| NCGC00263567-01 |
| P 071 |
| P-071 |
| PGLIUCLTXOYQMV-UHFFFAOYSA-N |
| Prestwick_841 |
| Reactine |
| Ressital |
| Riztec |
| RTR-026026 |
| Ryzen |
| s1291 |
| Salvalerg |
| SCHEMBL41107 |
| Setiral |
| SPECTRUM1505371 |
| SR-01000688282 |
| SR-01000688282-3 |
| ST077146 |
| ST24039138 |
| Stopaler |
| Sun mark all day allergy |
| SW196972-3 |
| Topcare all day allergy |
| Tox21_110704 |
| Tox21_110704_1 |
| Tox21_302261 |
| Tox21_500362 |
| Triz |
| UCB-P 071 |
| Up and up all day allergy relief |
| Virdos |
| Voltric |
| Xero-sed |
| Zerviate |
| Zetir |
| Zirtin |
| Zyrtec |
| Zyrtec (TN) |
| Zyrtec Allergy |
| Zyrtec-D |
| Zyrzine |
US Patents and Regulatory Information for ZYRTEC HIVES RELIEF
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| J And J Consumer Inc | ZYRTEC HIVES RELIEF | cetirizine hydrochloride | TABLET;ORAL | 019835-005 | Nov 16, 2007 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| J And J Consumer Inc | ZYRTEC HIVES RELIEF | cetirizine hydrochloride | TABLET;ORAL | 019835-006 | Nov 16, 2007 | DISCN | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
